CompletedNCT02698215
Varenicline With Naltrexone for Smoking Cessation
About this title
Read the official source — NCT02698215Medication studyAges 21–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 21 years to 65 years.
- Listed locations
- Los AngelesSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: May 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 165
- Sponsor
- University of California, Los Angeles
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT02698215
- Official title
Show the full official title
Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Los Angeles
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, Los Angeles, a university.
Did this study involve medication?
Yes. The study involved medication, including Varenicline and Varenicline plus Naltrexone.
Who was this study for?
Listed age limits: 21 years to 65 years.
